Currently out of the existing stock ratings of Alex Arfaei, 34 are a HOLD (33.66%), 53 are a BUY (52.48%), 14 are a SELL (13.86%).

Alex Arfaei

Work Performance Price Targets & Ratings Chart

Analyst Alex Arfaei, employed carries an average stock price target met ratio of 100% that have a potential upside of 35.21% achieved within 534 days on average. Previously, Alex Arfaei worked at BMO.

Alex Arfaei’s has documented 186 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ZTS, Zoetis at 09-May-2019.

Wall Street Analyst Alex Arfaei

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for ABBV (ABBVIE) at 5/23/2018. The price target of $78 was fulfilled within 2 days with a profit of $3.11 (3.83%) receiving and performance score of 19.17.

Average potential price target upside

ABBV AbbVie BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer AZN AstraZeneca PLC ADR KIN Kindred Biosciences ZTS Zoetis

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

190

$19.53 (11.46%)

180

6 days ago

38/39 (97.44%)

$18.61 (10.86%)

495

Buy

187

$16.53 (9.70%)

195

1 months 26 days ago

10/13 (76.92%)

$27.38 (17.15%)

191

Buy

189

$18.53 (10.87%)

181

4 months 18 days ago

9/11 (81.82%)

$15.71 (9.07%)

252

Buy

195

$24.53 (14.39%)

180

4 months 18 days ago

9/10 (90%)

$21.71 (12.53%)

445

Hold

165

$-5.47 (-3.21%)

157

5 months 7 days ago

11/11 (100%)

$2.96 (1.83%)

314

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Alex Arfaei?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?